Equities

Venus Remedies Ltd

VENUSREM:NSI

Venus Remedies Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)342.10
  • Today's Change-1.90 / -0.55%
  • Shares traded18.30k
  • 1 Year change+46.20%
  • Beta1.8722
Data delayed at least 15 minutes, as of Sep 20 2024 11:11 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue6,0145,5555,986
OPERATING EXPENSES
Cost of revenue total3,7133,4323,855
Selling, general and admin. expenses, total1,5471,2931,281
Depreciation/amortization264323335
Unusual expense(income)----0
Other operating expenses, total(5.08)(4.86)(4.63)
Total operating expense5,6785,2715,696
Operating income337284290
Other, net4.014.7069
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes446379364
Provision for income taxes162114(43)
Net income after taxes285266407
Minority interest------
Net income before extra. Items285266407
Total extraordinary items------
Net income285266407
Inc.avail. to common excl. extra. Items285266407
Inc.avail. to common incl. extra. Items285266407
EPS RECONCILIATION
Basic/primary weighted average shares131313
Basic/primary eps excl. extra items212031
Basic/primary eps incl. extra items212031
Dilution adjustment------
Diluted weighted average shares131313
Diluted eps excl. extra items212031
Diluted eps incl. extra items212031
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock00--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.941.181.98
SUPPLEMENTAL INCOME
Depreciation, supplemental174235248
Total special items----0
NORMALISED INCOME
Normalized income before taxes446379364
Effect of special items on income taxes----0
Income tax excluding impact of special items162114(43)
Normalized income after tax285266407
Normalized income avail. to common285266407
Basic normalized EPS212031
Diluted normalized EPS212031
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.